Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
12. September 2023 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
17. August 2023 18:20 ET
|
Anika Therapeutics Inc.
Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure, resulting in higher strength and greater...
Anika Reports Second Quarter 2023 Financial Results
08. August 2023 16:05 ET
|
Anika Therapeutics Inc.
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date Performance Hyalofast®, Single-Stage,...
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
20. Juli 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
12. Juli 2023 09:00 ET
|
Anika Therapeutics Inc.
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide time-saving regenerative solutions for Sports...
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
30. Mai 2023 16:05 ET
|
Anika Therapeutics Inc.
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it has been clinically demonstrated to be...
Anika Reports First Quarter 2023 Financial Results
09. Mai 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for...
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
19. April 2023 08:30 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Enters Into Cooperation Agreement with Caligan Partners
13. April 2023 17:00 ET
|
Anika Therapeutics Inc.
Gary Fischetti Joins Anika Board Announces Share Repurchase Program Forms Capital Allocation Committee BEDFORD, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK)...
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
12. April 2023 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...